Researchers at the Rajiv Gandhi Centre for Biotechnology (RGCB) here have published findings that could help reduce the risk of heart disease in patients with diabetes.
The researchers have pinpointed Cyclophilin A, a protein that plays a role in several diseases in humans, as a potential drug target for reducing heart disease risk in such patients.
Heart attacks result from the rupture of cholesterol plaque deposited on artery walls. A tear or rupture activates a repairing mechanism resulting in a blood clot. Such clots can block blood flow to the heart muscle, causing a heart attack.
.jpg?w=600)
